Shot chasers: big pharma’s covid-19 boost
The Intelligence from The Economist 
About this episode
<p>The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory’s increasingly fraught politics.&nbsp;</p><p>For full access to print, digital and audio editions of <em>The Economist</em>, subscribe here <a href="http://www.economist.com/radiooffer" rel="noopener noreferrer" target="_blank">www.economist.com/radiooffer</a></p> <hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Listen to this episode in English to learn English
Podcast episodes are one of the highest-density ways to absorb English at native pace. Shot chasers: big pharma’s covid-19 boost from The Intelligence from The Economist gives you natural dialogue, unscripted speech, and vocabulary that actually appears in real conversations.
In the Clue app, every word in the transcript is tappable. Tap an unknown word, see the translation in your language instantly, and keep listening without breaking flow.